Financial statements Detrapharm
Balance sheet data of DETRAPHARM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|---|---|---|---|---|
Total assets | 7 929,56 | 8 768,57 | 712 149,91 | 2 439 353,43 | 3 568 870,02 |
A. Fixed assets | 0,00 | 0,00 | 82 449,87 | 217 993,13 | 63 559,75 |
B. Current assets | 7 929,56 | 8 768,57 | 629 700,04 | 2 221 360,30 | 3 505 310,27 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | 0,00 |
Total liabilities | 7 929,56 | 8 768,57 | 712 149,91 | 2 439 353,43 | 3 568 870,02 |
A. Equity | 6 208,33 | 6 237,52 | -14 291,53 | -99 504,19 | 409 253,50 |
B. Liabilities and provisions for liabilities | 1 721,23 | 2 531,05 | 726 441,44 | 2 538 857,62 | 3 159 616,52 |
I. Long-term liabilities | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.